Reach out to us to learn how our EQ Connect tools can help your organization increase 340B savings & improve patient health outcomes.
In this piece Anthony Esgro, chief pharmacy officer at Equiscript, LLC, outlines strategies covered entities can employ to navigate increasing manufacturer restrictions and other sources of instability in the 340B program. https://lnkd.in/e5QKP6Fg #340B